Tuesday, January 03, 2023 4:05:19 PM
I will say most OTC company aren't real companies with real revenues. So they basically go through the process your mentions of reverse splitting the re diluting the stock and then reverse splitting with no real revenues.
Time will tell with how this plays out but I noticed that the mention in there press release that they would do "up to a 25 to 1 reverse split".
That tells me that it is a possibility worse case scenario as PPS will dictate that upon the move to up listing to a another exchange. That being said PPS will be dictated by what the company is doing in actual revenues.
However, we will still need to see them close on the merger first then see there business plan and numbers they post in there filings.
So it is still to early to say which way this will go.
We will know more as they make future announcements about the endeavor.
Time will tell with how this plays out but I noticed that the mention in there press release that they would do "up to a 25 to 1 reverse split".
That tells me that it is a possibility worse case scenario as PPS will dictate that upon the move to up listing to a another exchange. That being said PPS will be dictated by what the company is doing in actual revenues.
However, we will still need to see them close on the merger first then see there business plan and numbers they post in there filings.
So it is still to early to say which way this will go.
We will know more as they make future announcements about the endeavor.
Recent BRGX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2026 08:47:56 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 03:58:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 05:51:34 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2026 12:03:33 PM
- BioRegenx, Inc. (OTC: BRGX) Announces Major Corporate Progress, Auditor Transition, Technology Integration, and AI-Driven Strategic Vision • GlobeNewswire Inc. • 12/09/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 07:45:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:58:33 PM
